Jan 5th 2018: CytoDel completes series A financing

Pryor Cashman represented CytoDel, Inc. in connection with a private placement of Series A Convertible Preferred Stock to institutional accredited investors, led by a leading private equity fund that invests in significant scientific discoveries and supports them by providing capital and expertise. The offering closed on January 5, 2018.